Search

MSK researchers shed light on the signals that determine the fate of embryonic cells.

… Friday, June 16, 2017 Summary A new finding clarifies how certain proteins work together to direct cells to either specialize or remain pluripotent. This image, generated in the lab of developmental biologist Anna-Katerina (Kat) Hadjantonakis , shows mouse embryos arranged in three circles. The embryos

Neurosurgery research fellow Nelson Moussazadeh was awarded a research grant by Joseph and Nazee Moinian.

… Tuesday, September 9, 2014 Neurosurgery research fellow Nelson Moussazadeh was awarded a research grant by Joseph and Nazee Moinian in memory of Fariborz Nobandegani, a neurosurgeon who was passionate about research and patient care. This multiyear award will support Dr. Moussazadeh’s investigation into

MSK is committed to helping people with cancer live healthier, more satisfying lives during and after treatment. So that people don’t just survive cancer — they thrive.

… Thursday, April 10, 2025 Dear MSK Community, More people than ever before can expect to survive cancer. According to the National Cancer Institute, there are more than 18 million cancer survivors in the United States, and nearly half have lived 10 years or more. Cancer that spreads to other organs remains

A new study reports a possible way to quantify how efficient the immune system is at detecting cancer, and therefore how likely it is that a person will respond to immunotherapy.

… Thursday, November 7, 2019 Summary A study reports on a new way to determine who is most likely to benefit from immunotherapy. It may help explain why immunotherapy works differently in people around the world. Since 2011, the immunotherapy drugs called checkpoint inhibitors have become an increasingly

Memorial Sloan Kettering (MSK)’s Department of Marketing & Communications was awarded the Silver Award for Most Effective Media Plan in the 2021 Campaign US Media Awards.

… Tuesday, June 1, 2021 VIDEO | 01:00 Cancer care is essential care and it cannot wait. From testing for patients and staff, to enhanced safety measures, to telemedicine, we are making sure that you are able to get the care you need, when you need it, and where you need it. As always, our specialists treat

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce three faculty are among the 23 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2023. All three are members of the Sloan Kettering Institute, a hub for basic science and translational research within MSK.

… Thursday, April 6, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce three faculty are among the 23 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2023. All three are members of the

Memorial Sloan Kettering and Hackensack Meridian Health announced the Memorial Sloan Kettering–Hackensack Meridian Health partnership, a joint venture that will combine both organizations’ unparalleled expertise in all areas of cancer care and research to accelerate new discoveries and improve the lives of patients they jointly serve.

… Wednesday, December 14, 2016 The Two Organizations Will Develop New Standards of Cancer Care, Open Joint Cancer Treatment Facilities   NUTLEY, NJ, December 14, 2016 – Memorial Sloan Kettering Cancer Center and Hackensack Meridian Health today announced the Memorial Sloan Kettering–Hackensack Meridian

Memorial Sloan Kettering Cancer Center (MSK) announced today that physician-scientist Karuna Ganesh, MD, PhD, has been awarded a Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems in cancer research. Dr. Ganesh is part of an international team focused on developing new ways to “rewire” cancer cells and prevent treatment resistance in colorectal cancer, one of the leading causes of cancer-related deaths worldwide, and with rates rising among adults under 50.

… Wednesday, March 4, 2026 Memorial Sloan Kettering Cancer Center (MSK)  announced today that physician-scientist  Karuna Ganesh, MD, PhD, has been awarded a  Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems

A Q&A with Jaap-Jan Boelens, MD, PhD, Chief of the Pediatric Transplant and Cellular Therapy Service at MSK.

… Monday, December 9, 2024 MSK is the first hospital in New York City to offer gene therapy through its pediatric cancer program MSK Kids. Exagamglogene autotemcel (exa-cel) (Casgevy®) is a gene therapy for treating sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises

Cancer vaccines that use messenger RNA (mRNA) technology are an exciting new approach to develop immunotherapies for cancers with poor prognoses, such as pancreatic cancer.

… Wednesday, January 5, 2022 Cancer vaccines that use messenger RNA (mRNA) technology are an exciting new approach to develop immunotherapies for cancers with poor prognoses, such as pancreatic cancer. There is a tremendous, urgent need for new treatments for pancreatic cancer. Although the discovery of